Captrust Financial Advisors Senseonics Holdings, Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.94 - $1.94 $440 - $909	-469 Reduced 31.93%	1,000 $1,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $2,220 - $5,349	1,442 Added 5340.74%	1,469 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $69 - $105	27 New	27 $0
Q1 2020 May 15, 2020	SELL	$0.56 - $1.62 $11,200 - $32,400	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.83 - $1.3 $16,600 - $26,000	20,000 New	20,000 $18,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.